Literature DB >> 29348565

An in vitro system of autologous lymphocytes culture that allows the study of homeostatic proliferation mechanisms in human naive CD4 T-cells.

Isaac Rosado-Sánchez1, Amaia González-Magaña2, María M Pozo-Balado2, Inés Herrero-Fernández2, María J Polaino2, María M Rodríguez-Méndez2, María Francisca González-Escribano3, Manuel Leal2, Yolanda M Pacheco4.   

Abstract

The size of peripheral T-cell pool is kept constant throughout life. However, a decline in lymphocyte numbers is a feature of several human disorders, in which fast and slow homeostatic proliferation play a crucial role. Several in vitro and in vivo models have been developed to study such processes. Nevertheless, self- and commensal- antigens, well-known triggers of homeostatic proliferation, have not been examined in these models. We have designed an in vitro culture of human T-cells exposed to rIL7 and autologous antigen-presenting cells (aAPC) that allows the simultaneous characterization of the different types of homeostatic proliferation. Using our model, we first confirmed that both rIL7 and aAPC are survival signals ultimately leading to homeostatic proliferation. In addition, we explored the modulation of different anti-apoptotic, proliferative, activation and homing markers during fast and slow homeostatic proliferation. Finally, different subsets of Treg were generated during homeostatic proliferation in our model. In summary, our in vitro system is able to simultaneously reproduce both types of homeostatic proliferation of human naive CD4 T-cells, and allows the characterization of these processes. Our in vitro system is a useful tool to explore specific features of human homeostatic proliferation in different human lymphopenia-related disorders and could be used as a cell therapy approach.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29348565     DOI: 10.1038/s41374-017-0006-3

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  28 in total

Review 1.  Population biology of lymphocytes: the flight for survival.

Authors:  A A Freitas; B Rocha
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Both exogenous commensal and endogenous self antigens stimulate T cell proliferation under lymphopenic conditions.

Authors:  Jeong-su Do; Gilles Foucras; Nobuhiko Kamada; Austin F Schenk; Michael Shaw; Gabriel Nuñez; William E Paul; Booki Min
Journal:  Cell Immunol       Date:  2011-11-25       Impact factor: 4.868

3.  Age-dependent incidence, time course, and consequences of thymic renewal in adults.

Authors:  Frances T Hakim; Sarfraz A Memon; Rosemarie Cepeda; Elizabeth C Jones; Catherine K Chow; Claude Kasten-Sportes; Jeanne Odom; Barbara A Vance; Barbara L Christensen; Crystal L Mackall; Ronald E Gress
Journal:  J Clin Invest       Date:  2005-03-17       Impact factor: 14.808

4.  Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms.

Authors:  Booki Min; Hidehiro Yamane; Jane Hu-Li; William E Paul
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

Review 5.  Naive T cell homeostasis: from awareness of space to a sense of place.

Authors:  Kensuke Takada; Stephen C Jameson
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

6.  T-cell reconstitution after allogeneic stem cell transplantation: assessment by measurement of the sjTREC/βTREC ratio and thymic naive T cells.

Authors:  Simone Ringhoffer; Markus Rojewski; Hartmut Döhner; Donald Bunjes; Mark Ringhoffer
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

7.  Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/ MHC epitopes and strength of their interaction with T cell receptors.

Authors:  Q Ge; V P Rao; B K Cho; H N Eisen; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

8.  Memory T-cell predominance following T-cell depletional therapy derives from homeostatic expansion of naive T cells.

Authors:  A Sener; A L Tang; D L Farber
Journal:  Am J Transplant       Date:  2009-09-22       Impact factor: 8.086

Review 9.  T cell immune reconstitution following lymphodepletion.

Authors:  Kirsten M Williams; Frances T Hakim; Ronald E Gress
Journal:  Semin Immunol       Date:  2007-11-19       Impact factor: 11.130

Review 10.  Homeostasis of naive and memory T cells.

Authors:  Charles D Surh; Jonathan Sprent
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

View more
  4 in total

1.  Long-term T cell fitness and proliferation is driven by AMPK-dependent regulation of reactive oxygen species.

Authors:  Anouk Lepez; Tiphène Pirnay; Sébastien Denanglaire; David Perez-Morga; Marjorie Vermeersch; Oberdan Leo; Fabienne Andris
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

2.  HIV-Infected Subjects With Poor CD4 T-Cell Recovery Despite Effective Therapy Express High Levels of OX40 and α4β7 on CD4 T-Cells Prior Therapy Initiation.

Authors:  Isaac Rosado-Sánchez; Inés Herrero-Fernández; Miguel Genebat; Jorge Del Romero; Melchor Riera; Daniel Podzamczer; Julián Olalla; Francesc Vidal; Mª Angeles Muñoz-Fernández; Manuel Leal; Yolanda M Pacheco
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

3.  Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients.

Authors:  Qian Niu; Aleixandra Mendoza Rojas; Marjolein Dieterich; Dave L Roelen; Marian C Clahsen-van Groningen; Lanlan Wang; Teun van Gelder; Dennis A Hesselink; Nicole M van Besouw; Carla C Baan
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

4.  Increased Frequencies of Myeloid-Derived Suppressor Cells Precede Immunodiscordance in HIV-Infected Subjects.

Authors:  Isaac Rosado-Sánchez; Rebeca De Pablo-Bernal; Anna Rull; Juan Gónzalez; Santiago Moreno; David Vinuesa; Vicente Estrada; María Ángeles Muñoz-Fernández; Francesc Vidal; Manuel Leal; Yolanda María Pacheco
Journal:  Front Immunol       Date:  2020-11-06       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.